Omeprazole and lansoprazole are not inducers of cytochrome P4501A2 under conventional therapeutic conditions

European Journal of Clinical Pharmacology

Volumn 49, Issue 6, 1996, Pages 491-495

  Rizzo, N ^a   Padoin, C ^b   Palombo, S ^c   Scherrmann, J M ^a   Girre, C ^c  

^a HÔPITAL LARIBOISIÈRE   (France)

^b AVICENNE HOSPITAL   (France)

^c HÔPITAL FERNAND WIDAL   (France)

Author keywords

Caffeine; CYP1A2; Enzyme induction; Lansoprazole; Omeprazole

Indexed keywords

1 METHYLURIC ACID; 1 METHYLXANTHINE; 1,7 DIMETHYLURIC ACID; 5 ACETAMIDO 6 FORMYLAMINO 3 METHYLURACIL; CAFFEINE; CYTOCHROME P450; DRUG METABOLITE; LANSOPRAZOLE; OMEPRAZOLE;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DEMETHYLATION; DRUG METABOLISM; DRUG URINE LEVEL; ENZYME ACTIVITY; FEMALE; HUMAN; HUMAN EXPERIMENT; HYDROXYLATION; MALE; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; VOLUNTEER;

2-PYRIDINYLMETHYLSULFINYLBENZIMIDAZOLES; ADMINISTRATION, ORAL; ADULT; ANTI-ULCER AGENTS; CAFFEINE; CROSS-OVER STUDIES; CYTOCHROME P-450 CYP1A2; CYTOCHROME P-450 ENZYME SYSTEM; ENZYME INDUCTION; ENZYME INHIBITORS; FEMALE; H(+)-K(+)-EXCHANGING ATPASE; HUMANS; HYDROXYLATION; MALE; METHYLATION; MIDDLE AGED; OMEPRAZOLE; OXIDOREDUCTASES;

EID: 0029986312     PISSN: 00316970     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002280050055     Document Type: Article

References (27)

1. Nelson DR, Kamataki T, Waxman DJ, Guengerich FP, Estabrook RW, Feyereisen R, Gonzalez FJ, Coon MJ, Gunsamus IC, Gotoh O, Okuda K, Nebert DW (1993) The P450 superfamily: update on new sequences, gene mapping, accession numbers, early trivial names of enzymes, and nomenclature. D N A Cell Biol 12:1-51
2. Sesardic D, Boobis AR, Murray BP, Murray S, Segura J, DeLa Torre R, Davies DS (1990) Furafylline is a potent and selective inhibitor of cytochrome P4501A2 in man. Br J Clin Pharmacol 29:651-663
3. Farrell GC, Murray M (1990) Human cytochrome P450 isoforms. Gastroenterology 99:885-889
4. Parkinson A, Hurwitz A (1991) Omeprazole and the induction of Human Cytochrome P-450. A response to concerns about potentiel adverse effects. Gastroenterology 100:1157-1164
5. Wallmark B, Lorentzon P, Larsson H (1985) The mechanism of action of omeprazole - a survey of its inhibitory actions in vitro. Scand J Gastroenterol 20 [Suppl 108]: 37-51
6. Regardh CG, Gabrielsson M, Hoffman KJ, Löfberg I, Skanberg I (1985) Pharmacokinetics and metabolism of omeprazole in animals and man. An overview. Scand J Gastroenterol 20 [Suppl 108]: 79-94
7. Diaz D, Fabre I, Daujat M, Saint Aubert B, Bories P, Michel H, Maurel P (1990) Omeprazole is an aryl hydrocarbon-like inducer of human hepatic cytochrome P-450. Gastroenterology 99:737-747
8. Anderson T, Bergstrand R, Cederberg C, Eriksson S, Lagerström PO, Skanberg I (1991) Omeprazole treatment does not affect the metabolism of caffeine. Gastroenterology 101: 943-947
9. Campbell ME, Spielberg SP, Kalow W (1987) A urinary metabolite ratio that reflects systemic caffeine clearance. Clin Pharmacol Ther 42:157-165
10. PA (P-4501A2), the phenacetin-O-deethylase, is primarily responsible for the hepatic 3-demethylation of caffeine and N-oxidation of carcinogenic arylamines. Proc Natl Acad Sci USA 86:7696-7700
11. Kalow W, Tang BK (1993) The use of caffeine for enzyme assays: a critical appraisal. Clin Pharmacol Ther 53:503-514
12. Vistisen K, Loft S, Poulsen HE (1990) Cytochrome P4501A2 activity in man measured by caffeine metabolism: effect of smoking, broccoli and exercise. Adv Exp Med Biol 283:407-411
13. Conney AH, Pantuck EJ, Hsiao KC, Garland WA, Anderson KE, Alvares AP, Kappas A (1976) Enhanced phenacetin metabolism in human subjects fed charcoal-broiled beef. Clin Pharmacol Ther 20:633-642
14. Catteau A, Bechtel YC, Poisson N, Bechtel PR, Bonaïti-Pellie C (1995) A population and family study of CYP1A2 using caffeine urinary metabolites. Eur J Clin Pharmacol 47: 423-430
15. Grant DM, Tang BK, Kalow W (1983) Variability in caffeine metabolism. Clin Pharmacol Ther 33:591-602
16. Machin D, Campbell MJ, (1987) Statistical table for the design of clinical trials. Blackwell, Oxford, pp 47-48
17. Rost KL, Roots I (1994) Accelerated caffeine metabolism after omeprazole treatment is indicated by urinary metabolite ratios : coincidence with plasma clearance and breath test. Clin Pharmacol Ther 55:402-411
18. Campbell ME, Grant DM, Inaba T, Kalow W (1987) Biotrans-formation of caffeine, paraxanthine, theophylline, and theobromine by polycyclic aromatic hydrocarbon-inducible cytochrome(s) P450 in human liver microsomes. Drug Metab Dispo 15:237-249
19. Kalow W, Tang BK (1991) Caffeine as a metabolic probe: exploration of the enzyme-inducing effect of cigarette smoking. Clin Pharmacol Ther 49:44-48
20. Bologa M, Tang B, Klein J, Tesoro A, Koren G (1991) Pregnancy-induced changes in drug metabolism in epileptic women. J Pharmacol Exp Ther 257:735-740
21. Shaw-Stiffel TA, Tang BK, Spielberg SP, Shear NH (1988) Caffeine - a novel probe to assess drug effects on hepatic cytochrome P-450 activity [Abstract]. Hepatology 8:1385
22. Robson RA, Miners JO, Matthews AP, Stupans I, Meller D, McManus ME, Birkett DJ (1988) Characterization of theophylline metabolism by human liver microsomes. Biochem Pharmacol 37:1651-1659
23. Taburet AM, Geneve J, Bocquentin M, Simoneau G, Caulin C, Singlas E (1992) Theophylline steady state pharmacokinetics is not altered by omeprazole. Eur J Clin Pharmacol 42: 343-345
24. Gugler R, Jensen JC (1987) Drugs other than H2-receptor antagonists as clinically important inhibitors of drugs metabolism in vivo. Pharmacol Ther 33:133-137
25. Oosterhuis B, Jonkman J, Anderson T, Zuiderwijk P (1992) No influence of single intravenous doses of omeprazole on theophylline elimination kinetics. J Clin Pharmacol 32: 470-475
26. Nousbaum JB, Berthou F, Carlhant D, Riche C, Robasziekiewicz M, Gouerou H (1994) Four-week treatment with omeprazole increases the metabolism of caffeine. Am J Gastroenterol 89:371-375
27. Rost KL, Brösicke H, Heinmeyer G, Roots I (1994) Specific and dose-dependent enzyme induction by omeprazole in human beings. Hepatology 20:1204-1212